VeriMomБезопасен ли n-prolyl palmitoyl tripeptide-56 acetate при беременности?
No harmonised CLP reproductive classifications (ECHA Annex VI), no SCCS or CIR safety assessment flagging reproductive hazard, and no peer‑reviewed reproductive toxicity data identified (PubMed). As a peptide/lipopeptide there is no specific evidence of reproductive toxicity; therefore default hazard and mechanism scores are 0. Dermal absorption is expected to be low but measurable because of the palmitoyl lipophilic moiety, so exposure is scored low (e=1). Sources consulted: ECHA Annex VI, SCCS/CIR (no entries), PubMed (no reproductive studies), PubChem/CosIng (ingredient listing).
Pregnancy-safe products containing n-prolyl palmitoyl tripeptide-56 acetate
Related ingredients
Frequently asked questions
- Безопасен ли n-prolyl palmitoyl tripeptide-56 acetate при беременности?
- No harmonised CLP reproductive classifications (ECHA Annex VI), no SCCS or CIR safety assessment flagging reproductive hazard, and no peer‑reviewed reproductive toxicity data identified (PubMed). As a peptide/lipopeptide there is no specific evidence of reproductive toxicity; therefore default hazard and mechanism scores are 0. Dermal absorption is expected to be low but measurable because of the palmitoyl lipophilic moiety, so exposure is scored low (e=1). Sources consulted: ECHA Annex VI, SCCS/CIR (no entries), PubMed (no reproductive studies), PubChem/CosIng (ingredient listing).
- Безопасен ли n-prolyl palmitoyl tripeptide-56 acetate при грудном вскармливании?
- Same rationale as pregnancy: no reproductive or lactation-specific hazard identified in authoritative sources. No evidence of transfer in milk; dermal exposure from cosmetics is expected to be low but measurable (e=1). Sources: ECHA Annex VI, SCCS/CIR (no entries), PubMed, PubChem/CosIng.
- Безопасен ли n-prolyl palmitoyl tripeptide-56 acetate для кожи малыша?
- No infant‑specific hazard data located. Because the ingredient likely has low but measurable dermal absorption in adults (e=1) and infant skin has higher permeability and higher surface‑area‑to‑weight, exposure score is increased by +1 to e=2 for 0–3 year olds. No studies demonstrating infant toxicity were found. Sources: ECHA Annex VI, SCCS/CIR (no entries), PubMed, PubChem/CosIng.
- Как VeriMom оценивает n-prolyl palmitoyl tripeptide-56 acetate?
- VeriMom оценивает n-prolyl palmitoyl tripeptide-56 acetate в 93/100 (без известных рисков) на основе EU CosIng, классификаций ECHA и исследований PubMed.
- Какие безопасные альтернативы n-prolyl palmitoyl tripeptide-56 acetate при беременности?
- См. наш список безопасных альтернатив n-prolyl palmitoyl tripeptide-56 acetate с аналогичной функцией и классификацией без известных рисков.
Проверь любой состав за 2 секунды
Скачай VeriMom бесплатно — отсканируй любой продукт и мгновенно получи оценку безопасности при беременности.
Медицинская оговорка
Данная информация предоставлена исключительно в образовательных целях и не является медицинской рекомендацией. Оценки безопасности основаны на общедоступных данных и могут не отражать все риски. Всегда консультируйтесь с вашим врачом перед использованием любых средств во время беременности или грудного вскармливания.